AN ACT CONCERNING PRESCRIPTION DRUG SHORTAGES, PRESCRIPTION DRUG REBATES AND PROHIBITED MANUFACTURER PRACTICES CONCERNING CERTAIN PRESCRIPTION DRUGS.

Summary

The bill establishes a bipartisan task force to identify drugs at risk of shortage in Connecticut and recommend mitigation strategies. It also directs the Department of Economic and Community Development to broaden its Strategic Supply Chain Initiative to address those shortages, and it sets new rebate formulas that pharmaceutical manufacturers must pay to the Department of Social Services for drugs covered by state medical assistance programs. The measures aim to improve drug availability and reduce costs for patients relying on state assistance.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share